Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1984 Oct 1;160(4):1102-13.
doi: 10.1084/jem.160.4.1102.

Antigen presentation by hapten-specific B lymphocytes. I. Role of surface immunoglobulin receptors

Antigen presentation by hapten-specific B lymphocytes. I. Role of surface immunoglobulin receptors

K L Rock et al. J Exp Med. .

Abstract

The present study examines the ability of hapten-specific murine splenic B lymphocytes to present hapten-proteins to carrier-specific T cell hybridomas. BALB/cB cells specific for 2,4,6-trinitrophenyl (TNP) were isolated from spleens of immune mice by elution from TNP-gelatin-coated dishes. Such cells presented the TNP-modified terpolymer, GL phi, at concentrations as low as 0.1 microgram/ml, to a GL phi-specific, I-Ed-restricted, interleukin 2-producing T cell hybridoma. In contrast, the same B lymphocytes required 1,000-fold higher concentrations of unmodified GL phi to stimulate the same T cell hybridoma. The presentation of low concentrations of TNP-GL phi by TNP-specific B lymphocytes was significantly or completely blocked by anti-Ig antibody or TNP-proteins, indicating that surface Ig receptors were critically involved in this phenomenon. Finally, binding of TNP-proteins did not alter the ability of the B cells to present unrelated, unhaptenated proteins or to stimulate alloreactive T cells. These results suggest that surface Ig receptors serve to focus antigens onto specific B lymphocytes and that such cells are highly efficient at presenting linked antigenic determinants to T cells. The implications of these findings for the mechanisms of physiologic, histocompatibility-restricted T-B collaboration are discussed.

PubMed Disclaimer

References

    1. J Immunol. 1973 Feb;110(2):465-75 - PubMed
    1. Transplant Rev. 1975;22:175-95 - PubMed
    1. Adv Immunol. 1975;20:125-95 - PubMed
    1. J Exp Med. 1975 May 1;141(5):1004-14 - PubMed
    1. J Exp Med. 1978 Feb 1;147(2):554-70 - PubMed

Publication types